ANTIHYPERTENSIVE THERAPY IMPROVES REGIONAL MYOCARDIAL BLOOD-FLOW AND REDUCES PERFUSION DYSHOMOGENEITY IN PATIENTS WITH HYPERTENSION AND NO CORONARY-ARTERY DISEASE